Women's Health

  • Trying to get ahead of Alzheimer disease
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 517-518; DOI: https://doi.org/10.3949/ccjm.87b.09020

    Sorting out patients destined to have Alzheimer disease remains a challenge.

  • Emerging blood-based biomarkers for Alzheimer disease
    Lynn M. Bekris, PhD and James B. Leverenz, MD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 537-539; DOI: https://doi.org/10.3949/ccjm.87a.20133

    A blood test for Alzheimer disease could help in drug development and patient care.

  • Should women with HPV-related noncervical cancers be considered at high risk for cervical cancer?
    Suneela Vegunta, MD and Margaret E. Long, MD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 541-544; DOI: https://doi.org/10.3949/ccjm.87a.19145

    Yes. Lacking guidelines, close surveillance is prudent.

  • The HPV vaccine: Understanding and addressing barriers to vaccination
    Pelin Batur, MD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 545-548; DOI: https://doi.org/10.3949/ccjm.87a.20082

    Key steps include optimizing clinician-patient communication.

  • In Reply: Perinatal depression
    Maureen Sayres Van Niel, MD and Jennifer L. Payne, MD
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 456-457; DOI: https://doi.org/10.3949/ccjm.87c.08002
  • Perinatal depression
    Elise Laflamme, MD
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 456; DOI: https://doi.org/10.3949/ccjm.87c.08001
  • In Reply: DXA after menopause
    Kristi Tough DeSapri, MD and Rachel Brook, MD
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 457-458; DOI: https://doi.org/10.3949/ccjm.87c.08004
  • DXA after menopause
    Michael Balkin, MD
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 457; DOI: https://doi.org/10.3949/ccjm.87c.08003
  • Glucocorticoid-induced osteoporosis: Insights for the clinician
    CME article
    Shakaib Hayat, MD and Marina N. Magrey, MD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 417-426; DOI: https://doi.org/10.3949/ccjm.87a.19039

    Glucocorticoids cause significant bone loss, predominantly affecting trabecular bone, with consequent fragility fractures.

  • Vertebral fractures after denosumab cessation
    Jolan Dupont, MD, Michaël R. Laurent, MD,PhD, Lenore Dedeyne, MSc, Frank P. Luyten, MD,PhD, Evelien Gielen, MD,PhD and Marian Dejaeger, MD,PhD
    Cleveland Clinic Journal of Medicine June 2020, 87 (6) 337-338; DOI: https://doi.org/10.3949/ccjm.87a.19152

    The patient had a 6-month history of lumbar and dorsal back pain, initially suspected to be facet arthrosis.

Pages